Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions

By | December 16, 2021
The life science group Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH.